Literature DB >> 32530438

New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm.

Yogendra Kanthi1,2, Jason S Knight3, Yu Zuo3, David J Pinsky1,4.   

Abstract

Purinergic signaling is discussed as a potential therapeutic target to reduced COVID-19 severity.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32530438      PMCID： PMC7453890          DOI： 10.1172/jci.insight.140971

Source DB:  PubMed          Journal:  JCI Insight        ISSN： 2379-3708


  26 in total

Review 1.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

2.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

3.  Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.

Authors:  Vinita Yadav; Liguo Chi; Raymond Zhao; Benjamin E Tourdot; Srilakshmi Yalavarthi; Benjamin N Jacobs; Alison Banka; Hui Liao; Sharon Koonse; Anuli C Anyanwu; Scott H Visovatti; Michael A Holinstat; J Michelle Kahlenberg; Jason S Knight; David J Pinsky; Yogendra Kanthi
Journal:  J Clin Invest       Date:  2019-04-16       Impact factor: 14.808

4.  Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.

Authors:  Sonia Carta; Federica Penco; Rosa Lavieri; Alberto Martini; Charles Anthony Dinarello; Marco Gattorno; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

5.  Dipyridamole augments the antiinflammatory response during human endotoxemia.

Authors:  Bart P Ramakers; Niels P Riksen; Thijmen H Stal; Suzanne Heemskerk; Petra van den Broek; Wilbert H M Peters; Johannes G van der Hoeven; Paul Smits; Peter Pickkers
Journal:  Crit Care       Date:  2011-11-30       Impact factor: 9.097

6.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

Authors:  Marie-Luise von Brühl; Konstantin Stark; Alexander Steinhart; Sue Chandraratne; Ildiko Konrad; Michael Lorenz; Alexander Khandoga; Anca Tirniceriu; Raffaele Coletti; Maria Köllnberger; Robert A Byrne; Iina Laitinen; Axel Walch; Alexander Brill; Susanne Pfeiler; Davit Manukyan; Siegmund Braun; Philipp Lange; Julia Riegger; Jerry Ware; Annekathrin Eckart; Selgai Haidari; Martina Rudelius; Christian Schulz; Katrin Echtler; Volker Brinkmann; Markus Schwaiger; Klaus T Preissner; Denisa D Wagner; Nigel Mackman; Bernd Engelmann; Steffen Massberg
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

Review 7.  COVID-19-associated coagulopathy: An exploration of mechanisms.

Authors:  Meaghan E Colling; Yogendra Kanthi
Journal:  Vasc Med       Date:  2020-06-19       Impact factor: 3.239

8.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

9.  Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.

Authors:  Sharon E Fox; Aibek Akmatbekov; Jack L Harbert; Guang Li; J Quincy Brown; Richard S Vander Heide
Journal:  Lancet Respir Med       Date:  2020-05-27       Impact factor: 30.700

Review 10.  Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.

Authors:  Miriam Merad; Jerome C Martin
Journal:  Nat Rev Immunol       Date:  2020-05-06       Impact factor: 53.106
View more
  17 in total

1.  Horizons of Heparin Therapy in COVID-19 and Pandemic-Related Diseases.

Authors:  M V Kondashevskaya
Journal:  J Evol Biochem Physiol       Date:  2022-05-16       Impact factor: 1.621

Review 2.  Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.

Authors:  Dusan Hanidziar; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-06-09       Impact factor: 4.871

Review 3.  P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo-inflammation.

Authors:  Lyvia Lintzmaier Petiz; Talita Glaser; Julio Scharfstein; Mariusz Z Ratajczak; Henning Ulrich
Journal:  Stem Cell Rev Rep       Date:  2021-02-11       Impact factor: 5.739

Review 4.  Possible role of purinergic signaling in COVID-19.

Authors:  Maria Luiza Mukai Franciosi; Millena Daher Medeiros Lima; Maria Rosa Chitolina Schetinger; Andréia Machado Cardoso
Journal:  Mol Cell Biochem       Date:  2021-03-19       Impact factor: 3.396

Review 5.  From purines to purinergic signalling: molecular functions and human diseases.

Authors:  Zhao Huang; Na Xie; Peter Illes; Francesco Di Virgilio; Henning Ulrich; Alexey Semyanov; Alexei Verkhratsky; Beata Sperlagh; Shu-Guang Yu; Canhua Huang; Yong Tang
Journal:  Signal Transduct Target Ther       Date:  2021-04-28

6.  Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19.

Authors:  Yu Zuo; Shanea K Estes; Ramadan A Ali; Alex A Gandhi; Srilakshmi Yalavarthi; Hui Shi; Gautam Sule; Kelsey Gockman; Jacqueline A Madison; Melanie Zuo; Vinita Yadav; Jintao Wang; Wrenn Woodard; Sean P Lezak; Njira L Lugogo; Stephanie A Smith; James H Morrissey; Yogendra Kanthi; Jason S Knight
Journal:  Sci Transl Med       Date:  2020-11-02       Impact factor: 17.956

7.  Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.

Authors:  Hui Shi; Yu Zuo; Srilakshmi Yalavarthi; Kelsey Gockman; Melanie Zuo; Jacqueline A Madison; Christopher Blair; Wrenn Woodward; Sean P Lezak; Njira L Lugogo; Robert J Woods; Christian Lood; Jason S Knight; Yogendra Kanthi
Journal:  J Leukoc Biol       Date:  2020-09-01       Impact factor: 4.962

Review 8.  Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Physiol Rev       Date:  2020-10-30       Impact factor: 37.312

Review 9.  Inflammation, Infection and Venous Thromboembolism.

Authors:  Meaghan E Colling; Benjamin E Tourdot; Yogendra Kanthi
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

10.  Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19.

Authors:  Dusan Hanidziar; Simon C Robson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-10-14       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.